Studies of the HER-2/ <i>neu</i> Proto-Oncogene in Human Breast and Ovarian Cancer
-
- Dennis J. Slamon
- Division of Hematology-Oncology, Department of Medicine, and the Jonsson Comprehensive Cancer Center, U.C.L.A. School of Medicine, Los Angeles, CA 90024.
-
- William Godolphin
- Department of Clinical Chemistry, Vancouver General Hospital, Vancouver, Canada VSZIM9.
-
- Lovell A. Jones
- Department of Gynecology, M. D. Anderson Hospital, Houston, TX 77030.
-
- John A. Holt
- Department of Obstetrics and Gynecology, University of Chicago Medical Center, Chicago, IL 60637.
-
- Steven G. Wong
- Division of Hematology-Oncology, Department of Medicine, and the Jonsson Comprehensive Cancer Center, U.C.L.A. School of Medicine, Los Angeles, CA 90024.
-
- Duane E. Keith
- Division of Hematology-Oncology, Department of Medicine, and the Jonsson Comprehensive Cancer Center, U.C.L.A. School of Medicine, Los Angeles, CA 90024.
-
- Wendy J. Levin
- Division of Hematology-Oncology, Department of Medicine, and the Jonsson Comprehensive Cancer Center, U.C.L.A. School of Medicine, Los Angeles, CA 90024.
-
- Susan G. Stuart
- Triton Biosciences, Inc., Alameda, CA 94501.
-
- Judy Udove
- Department of Pathology, University of Southern California, School of Medicine, Los Angeles, CA 90033
-
- Axel Ullrich
- Department of Molecular Biology, Genentech, Inc., South San Francisco, CA 94080.
-
- Michael F. Press
- Department of Pathology, University of Southern California, School of Medicine, Los Angeles, CA 90033
抄録
<jats:p> Carcinoma of the breast and ovary account for one-third of all cancers occurring in women and together are responsible for approximately one-quarter of cancer-related deaths in females. The HER-2/ <jats:italic>neu</jats:italic> proto-oncogene is amplified in 25 to 30 percent of human primary breast cancers and this alteration is associated with disease behavior. In this report, several similarities were found in the biology of HER-2/ <jats:italic>neu</jats:italic> in breast and ovarian cancer, including a similar incidence of amplification, a direct correlation between amplification and over-expression, evidence of tumors in which overexpression occurs without amplification, and the association between gene alteration and clinical outcome. A comprehensive study of the gene and its products (RNA and protein) was simultaneously performed on a large number of both tumor types. This analysis identified several potential shortcomings of the various methods used to evaluate HER-2/ <jats:italic>neu</jats:italic> in these diseases (Southern, Northern, and Western blots, and immunohistochemistry) and provided information regarding considerations that should be addressed when studying a gene or gene product in human tissue. The data presented further support the concept that the HER-2/ <jats:italic>neu</jats:italic> gene may be involved in the pathogenesis of some human cancers. </jats:p>
収録刊行物
-
- Science
-
Science 244 (4905), 707-712, 1989-05-12
American Association for the Advancement of Science (AAAS)
- Tweet
キーワード
詳細情報
-
- CRID
- 1362825896239813888
-
- NII論文ID
- 80004644814
-
- ISSN
- 10959203
- 00368075
- http://id.crossref.org/issn/00368075
-
- データソース種別
-
- Crossref
- CiNii Articles